CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
atenolol +5 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000478
NCT00000478Phase 3Completed
CompareCT.gov

Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Mar 25, 2016

In Brief

A Phase 3 clinical trial evaluating atenolol, nifedipine, and 4 other interventions for Cardiovascular Diseases and 3 related conditions. Completed.

Detailed Summary

To assess the feasibility of and test the methodology for a full-scale clinical trial of therapies for asymptomatic cardiac ischemia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial Ischemia
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
19901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartNov 1, 1990
Study CompletionJun 1, 1997
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

atenololdrug

nifedipinedrug

diltiazemdrug

isosorbide dinitratedrug

coronary artery bypass coronary artery bypassprocedure

angioplasty, transluminal, percutaneous coronaryprocedure